5-(4-n-Propylphenyl)-5-oxovaleric acid, 95.0%, 100g

anti-DDDDK-tag mouse monoclonal, AP1501, 100 µg

2-Bromo-6-(bromomethyl)pyridine, 95.0%, 1g

6-[(4-Nitrobenzyl)thio]-9-beta-D-ribofuranosylpurine, 98.0%, 100mg

3-(Benzyloxy)-6-bromo-2-fluorophenol, 95.0%, 1g

1,4-Bis(4-nitrophenyl)piperazine, 98%, 1g

(E)-4-((4-ethoxyphenyl)diazenyl)benzene-1,3-diamine hydrochloride, 95+%, 200mg

2-Fluoro-biphenyl-5-ylboronic acid, 98+%, 5g

Boc-Val-Ala-PAB, 250mg

[1,1'-Bi(cyclohexane)]-4,4'-dione, 95.0%, 5g

2-tert-Butyl-4-chloro-6-methylpyrimidine, 95.0%, 25g

6-Methoxy-2-oxo-2H-chromene-3-carboxylic acid, 95+%, 100mg

2',4'-Dihydro-1'H-spiro[piperidine-4,3'-quinoline]-2'-one hydrochloride, 95.0%, 1g